FALCON THERAPEUTICS
Falcon Therapeutics Chapel Hill-based biotechnology company .The company is focused on developing a treatment of brain cancer with autologous neural stems cells that seek out and destroy cancer cells. It has filed two patents. It was founded by Shawn Hingtgen, a professor in the Division of Molecular Pharmaceutics at the UNC-Chapel Hill Eshelman School of Pharmacy.
FALCON THERAPEUTICS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
Chapel Hill, North Carolina, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
700 K USD
Current Employees Featured
Founder
More informations about "Falcon Therapeutics"
Falcon Therapeutics Company Profile 2024: Valuation, Funding ...
Falcon Therapeutics General Information Description. Developer of a personalized gene-modified cell therapy designed to kill cancer cells and minimize the potential of off-target toxicity.See details»
Falcon Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Falcon Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, Disease Domain:Neoplasms, Endocrinology and Metabolic Disease ...See details»
Falcon Therapeutics - Company Profile - Tracxn
Oct 31, 2024 Falcon Therapeutics ranks 1,344th among 2355 active competitors. 615 of its competitors are funded while 430 have exited. Overall, Falcon Therapeutics and its …See details»
Falcon Therapeutics Company Profile - Office Locations ... - Craft
Falcon Therapeutics is an early-stage cell therapy company intended to treat solid tumor cancers. Falcon creates a proprietary platform for treating cancer by turning a patient’s skin cells into …See details»
Falcon Therapeutics Inc. - VentureRadar
JW Therapeutics China Private JW Therapeutics is a leading cellular immunotherapy company with an integrated platform focusing on developing, manufacturing and commercializing …See details»
Falcon Therapeutics - Crunchbase
A Chapel Hill-based biotechnology company.See details»
Falcon Therapeutics - Funding, Financials, Valuation & Investors
Falcon Therapeutics has raised a total of . obfuscated. obfuscated. in funding over 1 round. This was a Venture - Series Unknown round raised on Jun 23, 2017. Which funding types raised …See details»
Falcon Therapeutics | VentureRadar
Falcon Therapeutics is developing an entirely new approach to Glioblastoma therapy that uses revolutionary stem cell technology to create personalized genetically engineered neural stem …See details»
Falcon Therapeutics - Overview, News & Competitors - ZoomInfo
Falcon Therapeutics. Business Services · North Carolina, United States · <25 Employees. Falcon Therapeutics Chapel Hill-based biotechnology company .The company is focused on …See details»
Falcon Therapeutics - VentureRadar
Similar Companies: Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, …See details»
FTX-101 - Drug Targets, Indications, Patents - Synapse - Patsnap
FTX-101, Initially developed by Falcon Therapeutics, Inc., Now, its global highest R&D status is Discontinued, Therapeutic Areas: Neoplasms,Digestive System Disorders,Endocrinology and …See details»
$1.5 Million Grant to Propel Falcon Therapeutics Cell Therapy to ...
Mar 10, 2019 Falcon Therapeutics, a Durham, NC based gene-modified cell therapy company, has been awarded a nearly $1,500,000 Phase II Small Business Technology Transfer (SBTT) …See details»
FTX-201 - Drug Targets, Indications, Patents - Synapse
FTX-201, Initially developed by Falcon Therapeutics, Inc., Now, its global highest R&D status is Preclinical, Therapeutic Areas: Neoplasms,Nervous System Diseases ...See details»
Falcon Therapeutics - Tech Stack, Apps, Patents & Trademarks
Organization. Falcon Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 5. ... This …See details»
www.falcontherapeutics.com
Www.falcontherapeutics.comSee details»
Falcon Therapeutics CEO and Key Executive Team | Craft.co
Falcon Therapeutics's CEO is Susan Nichols. Other executives include John Maslowski, Chairman; Shawn Hingtgen, Director and 2 others. See the full leadership team at Craft.See details»
Falcon Therapeutics - Contacts, Employees, Board Members
Organization. Falcon Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. …See details»
Innovator: Susan Nichols | UNC Innovation & Entrepreneurship
Susan Nichols is the CEO of Falcon Therapeutics and is best known in the global cell and gene therapy market as a business connectivity matchmaker, innovative commercial strategist and …See details»
FTX-401 - Drug Targets, Indications, Patents - Synapse
FTX-401, Initially developed by Falcon Therapeutics, Inc., Now, its global highest R&D status is Discontinued, Therapeutic Areas: Other Diseases.See details»